Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Kimberly-Clark
KMB
$36.4B
| $79.2M | 0.12% |
639,096
+310,042
| +94% | +$36M |
|
202
Johnson & Johnson
JNJ
$651B
| $79.1M | 0.12% |
565,572
+21,436
| +4% | +$2.87M |
|
203
Intel
INTC
$476B
| $79M | 0.12% |
1,470,366
-4,394,271
| -75% | -$223M |
|
204
ICU Medical
ICUI
$4.57B
| $78.2M | 0.12% |
326,635
+47,474
| +17% | +$11.4M |
|
205
Vulcan Materials
VMC
$35.8B
| $77.7M | 0.12% |
656,336
+121,718
| +23% | +$13.2M |
|
206
Petrobras Class A
PBR.A
$111B
| $77.6M | 0.12% |
5,426,745
-4,031,018
| -43% | -$56.4M |
|
207
Lyft
LYFT
$6.61B
| $76.7M | 0.11% |
+979,508
| New | +$76.7M |
|
208
PUT
PayPal
PYPL
$52.7B
| $76.7M | 0.11% |
738,500
+135,600
| +22% | +$12.8M |
|
|
OPTU
209
Optimum Communications Inc
OPTU
$323M
| $76.6M | 0.11% |
3,566,917
+1,825,295
| +105% | +$36.9M |
|
|
PARA
210
DELISTED
Paramount Global Class B
PARA
| $76.3M | 0.11% |
1,605,989
+1,270,691
| +379% | +$61.9M |
|
211
Burlington
BURL
$20.6B
| $75.9M | 0.11% |
484,461
+479,669
| +10,010% | +$77.3M |
|
212
Corning
GLW
$129B
| $75.9M | 0.11% |
2,292,496
-1,036,663
| -31% | -$34M |
|
|
ONCE
213
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $75.5M | 0.11% |
+662,880
| New | +$48.7M |
|
214
Keysight
KEYS
$53.8B
| $75.3M | 0.11% |
864,101
-566,655
| -40% | -$44M |
|
215
KeyCorp
KEY
$23.3B
| $74.7M | 0.11% |
4,744,733
-1,412,792
| -23% | -$23.6M |
|
216
Advance Auto Parts
AAP
$2.57B
| $74.6M | 0.11% |
437,357
-696,178
| -61% | -$112M |
|
217
IQVIA
IQV
$42.8B
| $74.4M | 0.11% |
517,508
+497,379
| +2,471% | +$66.3M |
|
218
Graphic Packaging
GPK
$3.54B
| $74.4M | 0.11% |
5,889,605
-4,186,298
| -42% | -$50.8M |
|
219
Centene
CNC
$32.1B
| $74.3M | 0.11% |
1,399,374
+821,128
| +142% | +$49.8M |
|
220
Evercore
EVR
$11.2B
| $74.3M | 0.11% |
816,141
-12,796
| -2% | -$1.12M |
|
221
NetApp
NTAP
$37.7B
| $74.1M | 0.11% |
1,068,128
+1,024,448
| +2,345% | +$66.1M |
|
222
Occidental Petroleum
OXY
$61.3B
| $73.9M | 0.11% |
1,116,701
-2,158,538
| -66% | -$142M |
|
223
Targa Resources
TRGP
$64.1B
| $73.9M | 0.11% |
1,777,728
+867,195
| +95% | +$36.4M |
|
224
ON Semiconductor
ON
$28.9B
| $73.6M | 0.11% |
3,576,279
+360,575
| +11% | +$7.44M |
|
225
iShares MSCI Taiwan ETF
EWT
$11.2B
| $73.4M | 0.11% |
2,122,619
+364,033
| +21% | +$12M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.